Brief: Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data From Phase 1 Proof-Of-Concept Trial Of Glyphago™ In Healthy Volunteers08/06/2026 12:06
Last trade - 00:00Last trade - 00:00Last trade - 00:00